• The Council will serve as an advisory group, guiding BVI on corporate strategy, unmet clinical needs, product development, and surgical best practices.
• This initiative marks a key step in BVI’s global expansion, with plans underway for a European Surgical Advisory Board to further strengthen international partnerships

WALTHAM, Mass., August 6th, 2025 – BVI, a leading global ophthalmic device company dedicated to sitting at the forefront of advancements in eye surgery, today announced the formation of its first U.S. Surgical Leadership Council. This distinguished group of seven leaders spans the fields of cataract, retina, and glaucoma surgery—each dedicated to shaping the future of ophthalmology through collaboration and insight-driven innovation.

The U.S. Surgical Leadership Council reflects BVI’s drive to work hand-in-hand with surgeons to co-develop meaningful solutions across the full spectrum of eye care. These members have been instrumental in guiding industry over the years and will now collaborate closer with BVI to help chart the course for the company’s next phase of growth.

“We are thrilled to partner with BVI as inaugural members of its U.S Surgical Council.  BVI has a longstanding commitment to excellence through innovation in surgical vision, and we look forward to helping introduce more of these innovations to the United States,” said George O. Waring IV, MD.

The inaugural council members include:

• Nicole Fram, MD
• Sumit (Sam) Garg, MD
• Nathan Radcliffe, MD
• Firas Rahhal, MD
• Vance Thompson, MD
• George O Waring IV, MD
• Robert J. Weinstock, MD

“The Council will serve as a strategic advisory council, enabling BVI to gather critical insights from frontline surgeons. In doing so, BVI aims to accelerate its efforts in delivering a differentiated, end-to-end portfolio of surgical solutions that truly reflect the voice of the customer,” said Andy Chang, Chief Commercial Officer.

This initiative marks a major milestone in BVI’s commitment to co-creating solutions with the ophthalmic community.

About BVI

BVI® is a diversified global ophthalmic device company with a mission to deliver high-quality solutions and innovation for advancing eye surgery and improving patients’ vision. With nine decades of developing leading products and solutions, BVI partners with ophthalmic surgeons to improve the vision of millions of patients across the globe. Our organization supports surgical teams in more than 90 countries worldwide, either directly or through our network of trusted distributors.

To learn more about BVI and its mission to advance the future of vision, visit https://www.bvimedical.com

***

Press Contact
David Chavez
Global Communications Lead
[email protected]
+1 (857) 869 8706

• BVI received four awards in the 2025 Medical Device Network Excellence Awards—for Innovation, Product Launches, R&D, and Investments—recognizing its leadership in advancing ophthalmic technology and global growth.
• Key achievements include the launch of SERENITY IOLs with ISOFOCAL technology, FDA clearance of the Leos™ glaucoma system, and a $1 billion capital raise supporting strategic expansion and continued innovation.

WALTHAM, Mass., July 9th, 2025 – BVI, a leading global ophthalmic device company dedicated to sitting at the forefront of advancements in eye surgery, has been recognized with four prestigious accolades in the 2025 Medical Device Network Excellence Awards. The company earned top honors in Innovation, Research and Development, Investments, and Product Launches, underscoring its leadership in advancing eye care technology, strategic growth, and breakthrough product development.

The Excellence Awards celebrate the most impactful achievements and innovations across the medical device industry. Powered by Global Data’s proprietary business intelligence, the program highlights the companies and individuals driving meaningful changes across twelve key categories including Innovation, Product Launches, R&D, Safety, and Marketing.

“Being recognized across four distinct categories is an extraordinary honor and a reflection of the energy and purpose that drive our teams every day,” said Shervin Korangy, President & Chief Executive Officer at BVI. “These awards validate our vision to lead the ophthalmic industry not only through cutting-edge technologies, but also through bold financial strategy and meaningful global expansion. We’re excited by the impact we’re making — and even more inspired by what’s ahead.”

BVI was recognized in the following categories:

• Breakthrough Innovation in Ophthalmic Implants: For its patented ISOFOCAL technology, featured in the newly launched SERENITY and SERENITY Toric premium monofocal IOLs.
• Award-Winning Product Launch: SERENITY IOL Portfolio: For introducing the SERENITY IOL series, representing the second generation of BVI’s ISOPURE family.
• R&D Leadership in Minimally Invasive Glaucoma Technology: For the Leos™ Laser Endoscopy Ophthalmic System, a groundbreaking platform that combines laser treatment with endoscopic visualization. Leos has received FDA 510(k) clearance and is planned for commercial launch in late 2025.
• Strategic Capital Investment and Global Expansion: Following the successful $1 billion capital raise in partnership with TPG, enabling manufacturing expansion, global footprint growth, and accelerated product innovation.

“Winning in both the Innovation and Product Launch categories is a powerful acknowledgment of the incredible work our teams have done to bring the SERENITY IOL portfolio to market,” said Andrew Chang, Chief Commercial Officer at BVI. “We’re proud to set a new standard in monofocal IOLs and excited for what lies ahead. With upcoming launches on the horizon, we remain deeply committed to shaping the future of ophthalmology.”

These four awards reflect the strength of BVI’s strategy, the depth of its innovation, and the dedication of its global teams. As the company continues to expand its portfolio, invest in next-generation technologies, and scale global operations, BVI is well-positioned to shape the future of ophthalmology and deliver lasting value to patients, surgeons, and partners around the world.

About BVI

BVI® is a diversified global ophthalmic device company with a mission to deliver high-quality solutions and innovation for advancing eye surgery and improving patients’ vision. With nine decades of developing leading products and solutions, BVI partners with ophthalmic surgeons to improve the vision of millions of patients across the globe. Our organization supports surgical teams in more than 90 countries worldwide, either directly or through our network of trusted distributors.

To learn more about BVI and its mission to advance the future of vision, visit https://www.bvimedical.com

---

Press Contact
David Chavez
Global Communications Lead
[email protected]
+1 (857) 869 8706

• Positions company for several new product launches and scaling of operations to meet rising demand globally

• $1 billion of new capital raised to refinance debt and fund accelerated growth

Waltham, MA, March 10th, 2025 – BVI Medical, a leading global ophthalmic device company dedicated to sitting at the forefront of advancements in eye surgery, today announced the completion of a $1 billion strategic capital raise in partnership with TPG, a leading global alternative asset management firm. This investment, which fully refinances BVI’s existing debt and adds new equity from both TPG and new investors, strengthens the company’s financial position as it looks to accelerate product innovation and expand its global footprint.

This financing follows a period of accelerated momentum for BVI, during which the company has significantly grown its portfolio of product offerings and built one of the most robust product pipelines in the industry. Most recently, BVI expanded its IOL manufacturing in Europe to meet growing global demand, introduced new product lines such as SERENITY and SERENITY Toric premium monofocal IOLs, and strengthened its market position through strategic acquisitions.

“This investment marks a pivotal moment for BVI as we scale our capabilities to meet the rising demand for advanced ophthalmic solutions,” said Shervin Korangy, President and CEO. “We are redefining the future of eye surgery and changing the competitive landscape by driving the launch of breakthrough technologies that will empower surgeons worldwide.”

“TPG is proud to continue our partnership with BVI as it works to scale its global impact in ophthalmic care,” said Kendall Garrison, Partner at TPG. “The company has strengthened its market position while advancing patient care worldwide and this investment will further drive innovation and expansion. We look forward to supporting BVI’s continued success,” added John Schilling, MD, Co-Managing Partner at TPG Capital.

---

About BVI Medical

BVI® is a diversified global ophthalmic device company with a mission to deliver high-quality solutions and innovation for advancing eye surgery and improving patients’ vision. With nine decades of developing leading products and solutions, BVI partners with ophthalmic surgeons to improve the vision of millions of patients across the globe. Our organization supports surgical teams in more than 90 countries worldwide, either directly or through our network of trusted distributors.

To learn more about BVI Medical and its mission to advance the future of vision, visit https://www.bvimedical.com.

Press Contact

• EyeXchange Solutions connects experienced and emerging surgeons across cataract, glaucoma, and retina specialties to share insights, refine techniques, and address complex cases.

• BVI Medical aims to facilitate a collaborative forum fostering learning in ophthalmology through video series, engaging email discussions, and interactive quizzes.

Waltham, MA, January 31st, 2024 – BVI Medical, a diversified global ophthalmic device company committed to advancing eye surgery and improving patients’ vision, is excited to introduce EyeXchange Solutions. This new platform is designed to advance vision care through a comprehensive program of educational resources and clinical support, empowering surgical decisions, enhancing provider experiences, reducing the economic burden on healthcare systems, and optimizing patient care in cataract, glaucoma, and retina specialties.

In an ever-evolving field, EyeXchange Solutions facilitates insights to surgeons to navigate complex cases, refine techniques, and engage in meaningful discussions about the future of ophthalmology. By connecting experienced professionals with younger generations of surgeons, the platform fosters a continuous exchange of perspectives and practical skills.

Platform’s Core Tenets

• Education & Support: Dedicated to continuous learning through peer-to-peer education (in person or on demand), case studies, interactive surveys, and both didactic and hands-on clinical experiences.

• Patient-Centricity: Focused on improving patient outcomes by addressing the challenges and complexities inherent in vision care.

• Knowledge Sharing: Promotes collaboration, through a central intelligence hub.

“EyeXchange Solutions is about creating conversations that matter—bringing people together to share insights and learn from one another’s experiences. At BVI Medical, we are committed to being a trusted thought partner in addressing the complexities of modern ophthalmic care,” said Aimee Shimamoto, Vice President, Co-Head Global Marketing at BVI Medical.

Key Features

• EyeXchange Talks: Video series hosted on EyeXchange Solutions’ official website or presented live at major events, moderated by respected leaders in the field.

• Physician Perspectives: Thought-provoking questions sent via email each month to encourage discussion and share insights.

• Interactive Quiz: Engaging quizzes offering participants the opportunity to expand their knowledge and apply new concepts in their practice.

Through this new platform, BVI Medical reaffirms its dedication to fostering meaningful dialogue within the ophthalmology community. EyeXchange Solutions aligns with the company’s mission to support professionals navigating complex cases while providing valuable insights into perioperative, procedural, and business practices.

To learn more and join the conversation, visit https://eyexchange.bvimedical.com/

***

About BVI Medical

BVI® is a diversified global ophthalmic device company with a mission to deliver high-quality solutions and innovation for advancing eye surgery and improving patients’ vision. With nine decades of developing leading products and solutions, BVI partners with ophthalmic surgeons to improve the vision of millions of patients across the globe. Our organization supports surgical teams in more than 90 countries worldwide, either directly or through our network of trusted distributors.

Press Contact

David Chavez, Global Communications Lead

[email protected] 

+1 (857) 869 8706